| Peptidoglycan | TLR2, NOD2 → NF-κB, MAPK | Immune modulation, suppression of excessive inflammation | Functional foods, immune-supportive products | Taverniti & Guglielmetti, 2011; Saito et al., 2020 |
| Lipoteichoic acid (LTA) | TLR2 → MyD88–NF-κB | Cytokine regulation, immune homeostasis | Functional foods, dietary supplements | Lebeer et al., 2010; Taverniti & Guglielmetti, 2011 |
| S-layer proteins | TLR2, DC-SIGN → NF-κB | Epithelial barrier protection, pathogen exclusion | Gut health foods, clinical nutrition | Konstantinov et al., 2008; Szabó et al., 2023 |
| Exopolysaccharides (EPS) | TLR2, C-type lectin receptors → MAPK | Antioxidant activity, gut barrier enhancement | Functional foods, metabolic health | Lebeer et al., 2010; Teame et al., 2020 |
| Short-chain fatty acids (SCFAs) | GPR41/43 → AMPK activation, HDAC inhibition | Barrier integrity, anti-inflammatory and metabolic regulation | Functional foods, feed additives | Kang et al., 2021 |
| Microbial DNA (CpG motifs) | TLR9 → IRF/NF-κB | Th1 activation, innate immune stimulation | Clinical and immune-supportive applications | Wischmeyer et al., 2016 |
| Inactivated LAB cells | PRR-mediated mucosal signaling | Reduced pathogen adhesion, gut stability | Animal feed | de Almada et al., 2016 |
| Cell wall fragments | NF-κB, MAPK modulation | Improved gut morphology, reduced inflammation | Livestock feed | Bhattarai et al., 2025 |
| Postbiotic metabolites | SCFA-related signaling pathways | Improved feed efficiency, growth performance | Livestock production | Cui et al., 2025 |